Skip to main content

Amgen Value Stock - Dividend - Research Selection

Amgen

ISIN: US0311621009, WKN: 867900

Market price date: 17.05.2022
Market price: 245,35 USD


Amgen Fundamental data and company key figures of the share

Annual reports in USD
Key figures 09-02-2022
Cash flow
Net operating cash flow 9.261.000.000
Capital Expenditures -880.000.000
Free cash flow 8.381.000.192
Balance sheet
Total Equity 6.700.000.000
Liabilities & Shareholders equity 61.165.000.000
Income statement
Net income 5.893.000.000
Eps (diluted) 10,339
Diluted shares outstanding 570.000.000
Net sales/revenue 25.979.000.000

Fundamental ratios calculated on: 17-05-2022

Ratios
Key figures 17-05-2022
Cash flow
P/C 15,10
   
P/FC 16,69
Balance sheet
ROI9,64
ROE10,95
Income statement
P/E23,73
Div. Yield2,80%
P/B20,87
P/S5,38


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolAMGN
Market Capitalization139.849.498.624,00 USD
CountryUnited States
IndicesDow Jones Industrial Average,MSCI World Index,NASDAQ 100,NASDAQ Comp.,S&P 500
SectorsBiotechnology
Raw Data SourceUS GAAP in Millionen USD
Stock Split1999-11-22,2.0000/1.0000; 1999-03-01,2.0000/1.0000; 1995-08-16,2.0000/1.0000; 1991-09-11,3.0000/1.0000; 1990-08-13,2.0000/1.0000
Internetwww.amgen.com


Description of the company

Amgen Inc. is a global biotechnology pioneer that discovers, develops, manufactures and delivers human therapeutics. Its medicines help millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis (RA), bone disease, and other serious illnesses. On December 10, 2012, the Company acquired all of the outstanding stock of deCODE Genetics (deCODE). In July 5, 2012, the Company acquired KAI Pharmaceuticals, a privately held company based in South San Francisco. In September 2013, Swedish Orphan Biovitrum AB (publ) (Sobi) announced that they have acquired the full rights to develop and commercialize Kineret (anakinra) from Amgen Inc for all therapeutic indications.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.amgen.com


NEWS


Amgen management to meet with Oppenheimer

2022-05-17
Meeting to be held in New... AMGN

5 Beaten-Down Blue-Chip Stocks to Buy Now

2022-05-17
These are the best blue-chip stocks to buy now. MMM, AMGN, BA, JPM, and MSFT can make great investments in the coming months.

SEC filings reveal massive selling in media names, including Disney and Comcast

2022-05-16
Leslie Picker joins the 'Halftime Report' to discuss what to expect from the SEC 13-F filings.

3 Dividend Stocks That Should Pay You for the Rest of Your Life

2022-05-16
If you've got some cash stored up, consider yourself a wise investor -- and fortunate. Now could be a great time to put that cash to use toward an investment in these three Dividend Kings that could provide robust returns for a lifetime.

Crispr Therapeutics appoints Morrow as CMO

2022-05-16
CRISPR Therapeutics (CRSP... CRSP, AMGN

BridgeBio (BBIO) Up on Deal With BMY for SHP2 Inhibitor

2022-05-13
BridgeBio (BBIO) forms an exclusive partnership with Bristol Myers (BMY) to develop and commercialize its SHP2 inhibitor.

The Zacks Analyst Blog Highlights Amgen, Altria Group, Uber Technologies, Microchip Technology, and Arista Networks

2022-05-13
Amgen, Altria Group, Uber Technologies, Microchip Technology, and Arista Networks are part of Zacks top Analyst Blog.

Dow Movers: AMGN, BA

2022-05-13
In early trading on Friday, shares of Boeing topped the list of the day's best performing Dow Jones Industrial Average components, trading up 4.3%. Year to date, Boeing has lost about 36.2% of its value.

These 5-Stock Samplers Have Gotten Whacked. And That's OK

2022-05-13
Our track record with 5-Stock Samplers has been simply astounding. So many times we've crushed the market! But remember when we said it wouldn't always be that way? That to win we sometimes have to lose? This is that time, Fools.

Video: Dow Movers: AMGN, BA

2022-05-13
In early trading on Friday, shares of Boeing topped the list of the day's best performing Dow Jones Industrial Average components, trading up 4.3% - Year to date, Boeing has lost about 36.2% of its value - AMGN,BA.